Fund profile
Tickers
IBBQ
Fund manager
Total assets
$20.97 mm
Liabilities
$4.66 mm
Net assets
$16.31 mm
Number of holdings
264.00
IBBQ stock data
Top 200 of 264 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 3.35 mm | 3.35 mm shares | 20.54 | Short-term investment vehicle | Long | USA |
AMGN AMGEN Inc. | 1.51 mm | 5.60 k shares | 9.26 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 1.46 mm | 4.12 k shares | 8.97 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 1.44 mm | 18.78 k shares | 8.82 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 1.43 mm | 1.74 k shares | 8.78 | Common equity | Long | USA |
Invesco Private Government Fund | 1.30 mm | 1.30 mm shares | 7.99 | Short-term investment vehicle | Long | USA |
SGEN Seagen Inc. | 699.12 k | 3.28 k shares | 4.29 | Common equity | Long | USA |
AstraZeneca PLC, ADR
|
657.40 k | 10.18 k shares | 4.03 | Common equity | Long | UK |
BIIB Biogen Inc | 592.22 k | 2.53 k shares | 3.63 | Common equity | Long | USA |
MRNA Moderna Inc | 516.71 k | 6.65 k shares | 3.17 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 367.29 k | 2.18 k shares | 2.25 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 299.56 k | 3.29 k shares | 1.84 | Common equity | Long | USA |
ILMN Illumina Inc | 281.99 k | 2.77 k shares | 1.73 | Common equity | Long | USA |
ARGX Argen X SE | 234.32 k | 520.00 shares | 1.44 | Common equity | Long | Netherlands |
SNY Sanofi | 230.34 k | 4.93 k shares | 1.41 | Common equity | Long | France |
INCY Incyte Corp. | 212.80 k | 3.92 k shares | 1.30 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 212.26 k | 7.84 k shares | 1.30 | Common equity | Long | UK |
NBIX Neurocrine Biosciences, Inc. | 198.90 k | 1.71 k shares | 1.22 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 196.80 k | 820.00 shares | 1.21 | Common equity | Long | USA |
VTRS Viatris Inc | 192.45 k | 20.96 k shares | 1.18 | Common equity | Long | USA |
BNTX BioNTech SE | 164.07 k | 1.63 k shares | 1.01 | Common equity | Long | Germany |
MEDP Medpace Holdings Inc | 144.56 k | 534.00 shares | 0.89 | Common equity | Long | USA |
BeiGene, Ltd., ADR
|
137.40 k | 735.00 shares | 0.84 | Common equity | Long | Cayman Islands |
SRPT Sarepta Therapeutics Inc | 132.57 k | 1.63 k shares | 0.81 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 130.53 k | 1.10 k shares | 0.80 | Common equity | Long | Ireland |
ROIV Roivant Sciences Ltd | 128.95 k | 13.49 k shares | 0.79 | Common equity | Long | Bermuda |
IMGN Immunogen, Inc. | 127.70 k | 4.35 k shares | 0.78 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 125.82 k | 658.00 shares | 0.77 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 123.92 k | 2.51 k shares | 0.76 | Common equity | Long | USA |
EXEL Exelixis Inc | 121.35 k | 5.56 k shares | 0.74 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 110.86 k | 2.06 k shares | 0.68 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 103.04 k | 1.68 k shares | 0.63 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 100.13 k | 997.00 shares | 0.61 | Common equity | Long | Denmark |
IMVT Immunovant Inc | 98.96 k | 2.53 k shares | 0.61 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 92.55 k | 1.39 k shares | 0.57 | Common equity | Long | Switzerland |
ABCZF Abcam plc | 89.86 k | 3.75 k shares | 0.55 | Common equity | Long | UK |
HALO Halozyme Therapeutics Inc. | 89.00 k | 2.31 k shares | 0.55 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 84.90 k | 1.64 k shares | 0.52 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 84.72 k | 1.39 k shares | 0.52 | Common equity | Long | Cayman Islands |
BBIO BridgeBio Pharma Inc | 81.57 k | 2.84 k shares | 0.50 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 73.82 k | 1.06 k shares | 0.45 | Common equity | Long | USA |
ALKS Alkermes plc | 70.22 k | 2.91 k shares | 0.43 | Common equity | Long | Ireland |
RVMD Revolution Medicines Inc | 68.85 k | 2.95 k shares | 0.42 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 67.70 k | 1.19 k shares | 0.42 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 65.67 k | 323.00 shares | 0.40 | Common equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 64.98 k | 994.00 shares | 0.40 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 63.74 k | 2.86 k shares | 0.39 | Common equity | Long | USA |
INSM Insmed Inc | 62.88 k | 2.51 k shares | 0.39 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 56.18 k | 1.68 k shares | 0.34 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 55.71 k | 1.43 k shares | 0.34 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 55.65 k | 825.00 shares | 0.34 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 55.27 k | 5.02 k shares | 0.34 | Common equity | Long | USA |
GH Guardant Health Inc | 51.75 k | 2.06 k shares | 0.32 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 50.97 k | 489.00 shares | 0.31 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 48.10 k | 854.00 shares | 0.29 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 45.78 k | 1.55 k shares | 0.28 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc | 44.52 k | 2.40 k shares | 0.27 | Common equity | Long | USA |
ACLX Arcellx Inc | 44.39 k | 845.00 shares | 0.27 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 42.95 k | 11.67 k shares | 0.26 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 41.08 k | 1.12 k shares | 0.25 | Common equity | Long | Canada |
ARWR Arrowhead Pharmaceuticals Inc. | 39.69 k | 1.87 k shares | 0.24 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 38.83 k | 1.38 k shares | 0.24 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 37.18 k | 4.39 k shares | 0.23 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 36.94 k | 1.93 k shares | 0.23 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals Inc | 36.75 k | 1.16 k shares | 0.23 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 36.67 k | 1.57 k shares | 0.22 | Common equity | Long | USA |
IDYA Ideaya Biosciences Inc | 35.35 k | 1.12 k shares | 0.22 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 33.25 k | 1.09 k shares | 0.20 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 33.20 k | 993.00 shares | 0.20 | Common equity | Long | USA |
VCYT Veracyte Inc | 32.51 k | 1.27 k shares | 0.20 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 30.51 k | 1.05 k shares | 0.19 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 30.49 k | 936.00 shares | 0.19 | Common equity | Long | Ireland |
PTCT PTC Therapeutics Inc | 30.39 k | 1.32 k shares | 0.19 | Common equity | Long | USA |
Immunocore Holdings PLC, ADR
|
30.16 k | 572.00 shares | 0.18 | Common equity | Long | UK |
MYGN Myriad Genetics, Inc. | 27.30 k | 1.43 k shares | 0.17 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 27.02 k | 2.73 k shares | 0.17 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 26.36 k | 4.34 k shares | 0.16 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 26.14 k | 815.00 shares | 0.16 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 26.02 k | 955.00 shares | 0.16 | Common equity | Long | USA |
Zai Lab Ltd., ADR
|
25.43 k | 932.00 shares | 0.16 | Common equity | Long | Cayman Islands |
MRUS Merus N.V | 24.91 k | 1.01 k shares | 0.15 | Common equity | Long | Netherlands |
SMMT Summit Therapeutics Inc | 24.72 k | 12.18 k shares | 0.15 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals Inc - Ordinary Shares | 24.48 k | 3.57 k shares | 0.15 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 24.15 k | 1.00 k shares | 0.15 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc | 23.78 k | 5.05 k shares | 0.15 | Common equity | Long | Canada |
Genmab A/S, ADR
|
23.23 k | 735.00 shares | 0.14 | Common equity | Long | Denmark |
NVCR NovoCure Ltd | 22.92 k | 1.87 k shares | 0.14 | Common equity | Long | Jersey |
VIR Vir Biotechnology Inc | 22.20 k | 2.34 k shares | 0.14 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 22.07 k | 809.00 shares | 0.14 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 21.63 k | 973.00 shares | 0.13 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc | 21.62 k | 2.50 k shares | 0.13 | Common equity | Long | Canada |
CVAC CureVac N.V. | 21.10 k | 3.91 k shares | 0.13 | Common equity | Long | Netherlands |
ARVN Arvinas Inc | 20.59 k | 937.00 shares | 0.13 | Common equity | Long | USA |
Grifols, S.A., ADR
|
20.58 k | 2.12 k shares | 0.13 | Common equity | Long | Spain |
SAGE Sage Therapeutics Inc | 20.48 k | 1.05 k shares | 0.13 | Common equity | Long | USA |
KYMR Kymera Therapeutics Inc | 20.18 k | 972.00 shares | 0.12 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals Inc | 20.17 k | 1.21 k shares | 0.12 | Common equity | Long | USA |
MORF Morphic Holding Inc | 19.84 k | 837.00 shares | 0.12 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 19.42 k | 3.30 k shares | 0.12 | Common equity | Long | USA |
XNCR Xencor Inc | 19.40 k | 1.06 k shares | 0.12 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 18.39 k | 1.01 k shares | 0.11 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 17.96 k | 1.56 k shares | 0.11 | Common equity | Long | Ireland |
GERN Geron Corp. | 17.72 k | 9.18 k shares | 0.11 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 17.67 k | 303.00 shares | 0.11 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals Inc | 17.65 k | 1.52 k shares | 0.11 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 17.63 k | 354.00 shares | 0.11 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 17.31 k | 1.37 k shares | 0.11 | Common equity | Long | USA |
ARDX Ardelyx Inc | 17.12 k | 3.80 k shares | 0.10 | Common equity | Long | USA |
MNKD Mannkind Corp | 16.97 k | 4.69 k shares | 0.10 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 16.93 k | 2.14 k shares | 0.10 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 16.64 k | 1.18 k shares | 0.10 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 16.32 k | 975.00 shares | 0.10 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 15.86 k | 1.17 k shares | 0.10 | Common equity | Long | UK |
INBX Inhibrx Inc | 15.83 k | 762.00 shares | 0.10 | Common equity | Long | USA |
INVA Innoviva Inc | 15.80 k | 1.14 k shares | 0.10 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 15.72 k | 1.01 k shares | 0.10 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 15.66 k | 516.00 shares | 0.10 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 15.51 k | 605.00 shares | 0.10 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 15.15 k | 1.20 k shares | 0.09 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 15.06 k | 1.43 k shares | 0.09 | Common equity | Long | USA |
RGNX Regenxbio Inc | 14.97 k | 767.00 shares | 0.09 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 14.58 k | 1.05 k shares | 0.09 | Common equity | Long | USA |
ADMA Adma Biologics Inc | 14.57 k | 3.94 k shares | 0.09 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 14.03 k | 3.46 k shares | 0.09 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals Inc | 13.93 k | 1.24 k shares | 0.09 | Common equity | Long | USA |
TNGX Tango Therapeutics Inc | 13.50 k | 1.78 k shares | 0.08 | Common equity | Long | USA |
GLPG Galapagos NV | 12.84 k | 343.00 shares | 0.08 | Common equity | Long | Belgium |
VERV Verve Therapeutics Inc | 12.64 k | 1.12 k shares | 0.08 | Common equity | Long | USA |
KURA Kura Oncology Inc | 12.60 k | 1.30 k shares | 0.08 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 11.74 k | 1.06 k shares | 0.07 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares | 11.71 k | 2.30 k shares | 0.07 | Common equity | Long | USA |
COGT Cogent Biosciences Inc | 11.51 k | 1.50 k shares | 0.07 | Common equity | Long | USA |
REPL Replimune Group Inc | 11.49 k | 1.03 k shares | 0.07 | Common equity | Long | USA |
NVAX Novavax, Inc. | 11.47 k | 2.09 k shares | 0.07 | Common equity | Long | USA |
HLVX HilleVax Inc | 11.26 k | 821.00 shares | 0.07 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 11.20 k | 468.00 shares | 0.07 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corp | 11.02 k | 2.52 k shares | 0.07 | Common equity | Long | USA |
ETNB 89bio Inc | 10.67 k | 1.33 k shares | 0.07 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 10.47 k | 543.00 shares | 0.06 | Common equity | Long | Cayman Islands |
RVNC Revance Therapeutics Inc | 10.46 k | 1.55 k shares | 0.06 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 10.41 k | 1.44 k shares | 0.06 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 10.20 k | 1.31 k shares | 0.06 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares | 9.91 k | 613.00 shares | 0.06 | Common equity | Long | Bermuda |
TBPH Theravance Biopharma Inc | 9.71 k | 927.00 shares | 0.06 | Common equity | Long | Cayman Islands |
BMEA Biomea Fusion Inc | 9.46 k | 628.00 shares | 0.06 | Common equity | Long | USA |
EOLS Evolus Inc | 9.38 k | 990.00 shares | 0.06 | Common equity | Long | USA |
CSTL Castle Biosciences Inc | 9.36 k | 468.00 shares | 0.06 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 9.32 k | 564.00 shares | 0.06 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 9.29 k | 730.00 shares | 0.06 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 9.16 k | 1.56 k shares | 0.06 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 9.14 k | 1.72 k shares | 0.06 | Common equity | Long | Singapore |
PETQ PetIQ Inc - Ordinary Shares | 8.94 k | 513.00 shares | 0.05 | Common equity | Long | USA |
MGNX Macrogenics Inc | 8.81 k | 1.07 k shares | 0.05 | Common equity | Long | USA |
RAPT RAPT Therapeutics Inc | 8.80 k | 606.00 shares | 0.05 | Common equity | Long | USA |
MXCT MaxCyte Inc | 8.65 k | 1.82 k shares | 0.05 | Common equity | Long | USA |
TVTX Travere Therapeutics Inc | 8.31 k | 1.32 k shares | 0.05 | Common equity | Long | USA |
ALEC Alector Inc | 8.01 k | 1.48 k shares | 0.05 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals Inc | 8.00 k | 1.66 k shares | 0.05 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 7.63 k | 4.41 k shares | 0.05 | Common equity | Long | USA |
BLUE Bluebird bio Inc | 7.21 k | 1.89 k shares | 0.04 | Common equity | Long | USA |
URGN UroGen Pharma Ltd | 7.04 k | 534.00 shares | 0.04 | Common equity | Long | Israel |
PHAT Phathom Pharmaceuticals Inc | 6.89 k | 986.00 shares | 0.04 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 6.84 k | 2.91 k shares | 0.04 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 6.72 k | 1.11 k shares | 0.04 | Common equity | Long | USA |
SIGA SIGA Technologies Inc | 6.70 k | 1.23 k shares | 0.04 | Common equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 6.70 k | 465.00 shares | 0.04 | Common equity | Long | UK |
ALXO Alx Oncology Holdings Inc | 6.59 k | 841.00 shares | 0.04 | Common equity | Long | USA |
ANAB AnaptysBio Inc | 6.53 k | 462.00 shares | 0.04 | Common equity | Long | USA |
CGEM Cullinan Therapeutics Inc | 6.15 k | 751.00 shares | 0.04 | Common equity | Long | USA |
NAUT Nautilus Biotechnology Inc | 6.06 k | 2.20 k shares | 0.04 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corp | 6.06 k | 2.96 k shares | 0.04 | Common equity | Long | Canada |
ITOS ITeos Therapeutics Inc | 5.92 k | 633.00 shares | 0.04 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals Inc | 5.90 k | 877.00 shares | 0.04 | Common equity | Long | USA |
GRCL Gracell Biotechnologies Inc | 5.81 k | 1.19 k shares | 0.04 | Common equity | Long | Cayman Islands |
QURE uniQure N.V. | 5.73 k | 845.00 shares | 0.04 | Common equity | Long | Netherlands |
HROW Harrow Inc | 5.65 k | 612.00 shares | 0.03 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 5.60 k | 933.00 shares | 0.03 | Common equity | Long | UK |
MGTX MeiraGTx Holdings plc | 5.38 k | 1.03 k shares | 0.03 | Common equity | Long | Cayman Islands |
AMRN Amarin Corp | 5.31 k | 6.79 k shares | 0.03 | Common equity | Long | UK |
NRIX Nurix Therapeutics Inc | 5.29 k | 850.00 shares | 0.03 | Common equity | Long | USA |
FULC Fulcrum Therapeutics Inc | 5.27 k | 1.10 k shares | 0.03 | Common equity | Long | USA |
PGEN Precigen Inc | 5.04 k | 4.50 k shares | 0.03 | Common equity | Long | USA |
HUMA Humacyte Inc | 4.86 k | 1.83 k shares | 0.03 | Common equity | Long | USA |
TERN Terns Pharmaceuticals Inc | 4.81 k | 1.08 k shares | 0.03 | Common equity | Long | USA |
EXAI Exscientia Plc | 4.80 k | 787.00 shares | 0.03 | Common equity | Long | UK |
ME 23andMe Holding Co - Ordinary Shares | 4.57 k | 5.31 k shares | 0.03 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals Inc | 4.54 k | 4.28 k shares | 0.03 | Common equity | Long | USA |
XERS Xeris Pharmaceuticals Inc | 4.53 k | 2.43 k shares | 0.03 | Common equity | Long | USA |
ERAS Erasca Inc | 4.45 k | 2.62 k shares | 0.03 | Common equity | Long | USA |
PSTX Poseida Therapeutics Inc | 4.39 k | 1.65 k shares | 0.03 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals Inc | 4.39 k | 1.47 k shares | 0.03 | Common equity | Long | USA |
FATE Fate Therapeutics Inc | 4.33 k | 1.74 k shares | 0.03 | Common equity | Long | USA |
CHRS Coherus Biosciences Inc | 4.06 k | 1.91 k shares | 0.02 | Common equity | Long | USA |
IGMS IGM Biosciences Inc | 3.96 k | 588.00 shares | 0.02 | Common equity | Long | USA |
RPTX Repare Therapeutics Inc | 3.84 k | 746.00 shares | 0.02 | Common equity | Long | Canada |
ALVR AlloVir Inc | 3.84 k | 2.04 k shares | 0.02 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc | 3.77 k | 1.01 k shares | 0.02 | Common equity | Long | USA |
RNAC Cartesian Therapeutics Inc | 3.55 k | 2.63 k shares | 0.02 | Common equity | Long | USA |
ENTA Enanta Pharmaceuticals Inc | 3.51 k | 376.00 shares | 0.02 | Common equity | Long | USA |
OCUL Ocular Therapeutix Inc | 3.49 k | 1.41 k shares | 0.02 | Common equity | Long | USA |